Related Experiment Video
Updated: Jul 5, 2025

08:30
Isolation of Group 2 Innate Lymphoid Cells from Mouse Nasal Mucosa to Detect the Expression of CD226
Published on: May 10, 2022
2.0K
Immunobiology of IL-26
Michel Gilliet1, Robert L Modlin2
1Department of Dermatology, CHUV University Hospital and University of Lausanne (UNIL), Lausanne, Switzerland.
The Journal of Investigative Dermatology
|January 11, 2024
Summary
Interleukin-26 (IL-26) is a unique cytokine produced by T helper 17 (Th17) cells with direct antimicrobial activity. This finding highlights IL-26 as a potential therapeutic target for infections and autoimmune diseases.
Area of Science:
- Immunology
- Cell Biology
- Microbiology
Background:
- T helper 17 (Th17) cells are crucial for host defense and autoimmunity, producing various cytokines like IL-17, IL-21, IL-22, and IL-26.
- While Th17 cytokines mediate inflammation and combat extracellular infections, their specific roles and mechanisms vary.
- IL-26 is unique among Th17 cytokines for its direct antimicrobial properties and immune cell activation capabilities.
Purpose of the Study:
- To elucidate the distinct functional role of Interleukin-26 (IL-26) among T helper 17 (Th17) cell-derived cytokines.
- To investigate the potential of IL-26 as a therapeutic target for infectious and autoimmune diseases.
Main Methods:
- Comparative analysis of cytokine profiles from Th17 cells.
- Assessment of IL-26's direct antimicrobial activity against various microbes.
- Evaluation of IL-26's capacity to activate immune cells via DNA binding and pattern recognition receptor triggering.
- Cross-species comparison of IL-26 expression, noting its absence in rodents.
Main Results:
- IL-26 exhibits direct antimicrobial activity, distinguishing it from other Th17 cytokines.
- IL-26 can activate a broad spectrum of immune cells by binding DNA and engaging pattern recognition receptors.
- IL-26 is produced by human Th17 cells but is absent in rodents, suggesting a specific mammalian role.
Conclusions:
- IL-26 possesses unique direct antimicrobial functions and immune-modulatory capabilities.
- The distinct properties of IL-26 position it as a promising therapeutic target for augmenting host defense against pathogens.
- Targeting IL-26 may offer novel strategies for managing autoimmune diseases by modulating inflammation and tissue damage.

